Portal de Periódicos da CAPES

Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide

2010; Elsevier BV; Volume: 49; Issue: 3 Linguagem: Inglês

10.1016/j.yjmcc.2010.02.003

1095-8584

Kana Shimada, Taka-aki Okabe, Yu Mikami, Miki Hattori, Masatoshi Fujita, Chiharu Kishimoto,

Transplantation: Methods and Outcomes

We systematically investigated serial efficacy of granulocyte colony-stimulating factor (G-CSF) therapy upon experimental autoimmune myocarditis (EAM) in rats treated with and without the inhibition of nitric oxide (NO) with the analyses of tissue regeneration. G-CSF could mobilize multipotent progenitor cells of bone marrow into the peripheral blood and may improve ventricular function. A rat model of porcine myosin-induced EAM was used. After the immunization of myosin, G-CSF (10 μg/kg/day) or saline was injected intraperitoneally on days 0–21 in experiment 1 and on days 21–42 in experiment 2. Additional myosin-immunized rats were orally given 25 mg/kg/day of NG-nitro-l-arginine methylester (l-NAME), an inhibitor of nitric oxide synthase (NOS), in each experiment (each group; n=8–21). Serum cytokines and peripheral blood cell counts were measured in each group. In experiment 1, G-CSF treatment aggravated cardiac pathology associated with increased macrophage inflammatory protein-2 (MIP-2) and interleukin-6 (IL-6) levels and enhanced superoxide production. In experiment 2, G-CSF treatment reduced the severity of myocarditis with increased capillary density and improved left ventricular ejection fraction. In the rats with EAM treated with G-CSF associated with oral l-NAME treatment in experiment 2, the severity of myocarditis was not reduced. Myocardial c-kit+ cells were demonstrated only in G-CSF-treated group in experiment 2 but not in other groups. G-CSF has differential effects on EAM in rats associated with the modulation of cytokine network. The overwhelming superoxide production by G-CSF administration in the acute stage may worsen the disease. G-CSF therapy improved cardiac function via NO system in a rat model of myocarditis in the chronic stage, but not in the acute stage, possibly through the myocardial regeneration and acceleration of healing process.